主持国家自然科学基金青年基金项目一项 ，参与省自然科学基金面上项目一项，参与江苏省卫生健康委

重点A类项目一项。

发表的同行评议论文

1.Wu Y, Li L, Wang Q, Zhang L, He C, Wang X, Liu H. LINC00511 promotes lung squamous cell carcinoma proliferation and migration via inhibiting miR-150-5p and activating TADA1. Transl Lung Cancer Res. 2020 Aug;9(4):1138-1148.

2.Wu Y, Zhang Y, Zhu X, Liu H. The Association of Long Non-Coding RNA SNHG6 Expression with Clinicopathological Features and Prognosis in Cancer. Clin Lab. 2019 Nov 1;65(11).

3.Wu Y, Huang J, Wang Q, Zhang M, Luo Y, Wang X, Zhu X, Liu H. Whole-exome sequencing insights into pulmonary artery sarcoma mimicking pulmonary embolism: a case report and review. Onco Targets Ther. 2019 Aug 7;12:6227-6235.

4.Wu Y, Ding M, Wei S, Wu T, Xu R, Zhu X, Liu H. The prognostic value of long noncoding RNA ZEB1-AS1 on clinical outcomes in human cancer. J Cancer. 2018 Sep 8;9(20):3690-3698.

5.Wu Y, Lyu H, Liu H, Shi X, Song Y, Liu B. Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer. Sci Rep. 2016 Aug 4;6:31093.

6.Wu Y, Liu H, Shi X, Yao Y, Yang W, Song Y. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma. Oncotarget. 2015 Apr 20;6(11):9160-72.

7.Wu Y, Liu H, Shi X, Song Y. Can EGFR mutations in plasma or serum be predictive markers of non-small-cell lung cancer? A meta-analysis. Lung Cancer. 2015 Jun;88(3):246-53.

8.Wu Y, Liu HB, Shi XF, Song Y. Conventional hypoglycaemic agents and the risk of lung cancer in patients with diabetes: a meta-analysis. PLoS One. 2014 Jun 12;9(6):e99577.

9.Wu Y, Liu HB, Ding M et al. The impact of E-cadherin expression on non-small cell lung cancer survival: a meta-analysis. Mol Biol Rep 2012, 39(10): 9621-8.

10.Wu Y, Liu HB, Ding M, et al. Association between the -1438G/A and T102C polymorphisms of 5-HT2A receptor gene and obstructive sleep apnea: a meta-analysis. Mol Biol Rep. 2013 Nov;40(11):6223-31.

11.Liu H, Wu Y, Zhu S, Liang W, Wang Z, Wang Y, Lv T, Yao Y, Yuan D, Song Y. PTP1B promotes cell proliferation and metastasis through activating src and ERK1/2 in non-small cell lung cancer. Cancer Lett. 2015 Apr 10;359(2):218-25.

12.Ding M, Wu Y, Jing H, Wei S, Wu T, Li XQ, Li P, Zhu X. Endobronchial ultrasound elastography for differentiating between benign and malignant lymph nodes: a meta-analysis. Minerva Med. 2019 Sep 27.

13.Liu HB, Wu Y, Lv TF, et al. Skin rash could predict the response to EGFR tyrosine kinase inhibitor and the prognosis for patients with non-small cell lung cancer: a systematic review and meta-analysis. PLoS One. 2013, 8(1).

14.Liu H, Wu Y, Wang Z, Song Y. Response to first-line chemotherapy of docetaxel combined with platinum predicting the prognosis and subsequent treatment of patients with non-small cell lung cancer. Thorac Cancer. 2014 Jul;5(4):337-42.

15.Liu H, Wu Y, Wang Z, Yao Y, Chen F, Zhang H, Wang Y, Song Y. Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer. J Thorac Dis. 2013 Dec;5(6):783-9.

16.Zhu Q, Lv T, Wu Y, Shi X, Liu H, Song Y. Long non-coding RNA 00312 regulated by HOXA5 inhibits tumour proliferation and promotes apoptosis in Non-small cell lung cancer. J Cell Mol Med. 2017 Sep;21(9):2184-2198.

17.Shi X, Sun M, Wu Y, Yao Y, Liu H, Wu G, Yuan D, Song Y. Post-transcriptional regulation of long noncoding RNAs in cancer. Tumour Biol. 2015 Feb;36(2):503-13.

18.Wei S, Wu T, Wu Y, Ming D, Zhu X. Diagnostic accuracy of Candida albicans germ tube antibody for invasive candidiasis: systematic review and meta-analysis. Diagn Microbiol Infect Dis. 2019 Apr;93(4):339-345.

19.Liu H, Gu X, Lv T, Wu Y, Xiao Y, Yuan D, Li Y, Song Y. The role of serum carcinoembryonic antigen in predicting responses to chemotherapy and survival in patients with non-small cell lung cancer. J Cancer Res Ther. 2014 Apr-Jun;10(2):239-43.

20.Hua X, Chen J, Wu Y, Sha J, Han S, Zhu X. Prognostic role of the advanced lung cancer inflammation index in cancer patients: a meta-analysis. World J Surg Oncol. 2019 Nov 2;17(1):177.

21.Zhan P, Zhang B, Xi GM, Wu Y, Liu HB, Liu YF, Xu WJ, Zhu QQ, Cai F, Zhou ZJ, Miu YY, Wang XX, Jin JJ, Li Q, Qian LP, Lv TF, Song Y. PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway. Mol Cancer. 2017 Jun 24;16(1):108.

22.Zhan P, Xi GM, Zhang B, Wu Y, Liu HB, Liu YF, Xu WJ, Zhu Q, Cai F, Zhou ZJ, Miu YY, Wang XX, Jin JJ, Li Q, Lv TF, Song Y. NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma. J Cell Mol Med. 2017 Apr;21(4):665-676.

23.Hua X, Han SH, Wei SZ, Wu Y, Sha J, Zhu XL. Clinical features of pulmonary embolism in patients with lung cancer: A meta-analysis. PLoS One. 2019 Sep 30;14(9):e0223230.

24.Hua X, Sun Y, Chen J, Wu Y, Sha J, Han S, Zhu X. Circular RNAs in drug resistant tumors. Biomed Pharmacother. 2019 Oct;118:109233.